What are the top 10 STDs and why do they matter
Sexually transmitted diseases (STDs), also called sexually transmitted infections (STIs), are infections passed mainly through sexual contact. Across regions and over time, some STDs remain among the most frequently reported notifiable conditions worldwide. Understanding the most common infections helps people make informed decisions about sexual health, testing, and protection. This overview focuses on well-established, globally relevant data and practical steps for prevention, care, and reliable support. While specific rankings can vary by region and reporting year, the conditions below consistently appear among the top 10 most commonly diagnosed STDs in public health surveillance.
How STDs are classified and reported
Public health agencies classify and report STDs based on case reporting, laboratory data, and surveillance programs. Notifiable conditions must be reported by clinicians and laboratories to health departments, allowing agencies to track incidence, prevalence, and trends. Because screening practices, diagnostic criteria, and reporting completeness vary, rankings by case count do not necessarily reflect biological severity or individual risk. Incidence indicates new cases in a year; prevalence reflects all existing cases at a point in time. Many infections are underdiagnosed due to asymptomatic carriage or limited access to care, which affects reported totals. These distinctions matter when interpreting lists and comparing regions or time periods.
Key reporting concepts
- Notifiable disease: Conditions health authorities require clinicians and labs to report.
- Incidence: Number of new cases in a defined period.
- Prevalence: Total number of existing cases at a specific time.
- Underdiagnosis: Infections not detected or reported, often without clear national totals.
Common factors that increase STD risk
Certain behaviors and circumstances raise the likelihood of acquiring or transmitting an STD. Multiple or new partners, inconsistent condom use, and earlier age at first intercourse correlate with higher risk. Having another STD, especially one that causes genital ulcers, increases susceptibility to acquiring others, including HIV. Social determinants such as poverty, limited healthcare access, stigma, and partner violence also influence risk and reporting. Recognizing these factors supports targeted prevention and timely testing.
Core topics covered
- Top 10 list based on commonly reported notifiable data, primarily from U.S. national surveillance and comparable global sources.
- Typical signs and when testing is advised, noting that many infections cause few or no symptoms.
- Diagnostic approaches, including lab tests and clinical exams, and why repeat testing may be needed.
- Treatment options, cure versus management, and the importance of partner notification and re-testing.
- Prevention strategies such as condoms, vaccination, testing frequency, and risk reduction.
Top 10 STD overview
The following list reflects commonly reported notifiable STDs that consistently rank among the top 10 in U.S. surveillance and many global reports. Rankings vary by jurisdiction and year, so treat this as an indicative set rather than a strict ordered list. Each entry includes the pathogen, key clinical features, typical testing methods, curability or management approach, and notes on prevention. Use this as a starting point for personal risk assessment and conversations with healthcare providers.
1) Chlamydia
Chlamydia trachomatis is frequently the most commonly reported bacterial STD in many regions, particularly among young people. It often causes no symptoms, especially in people with cervixes, where it can lead to pelvic inflammatory disease (PID) and infertility if untreated. Testing usually involves nucleic acid amplification tests (NAATs) on urine or swabs. Chlamydia is typically curable with antibiotics. Reinfection is common, so retesting after treatment is recommended. Consistent condom use reduces transmission risk.
2) Gonorrhea
Neisseria gonorrhoeae causes gonorrhea, which can infect the urethra, cervix, rectum, throat, and eyes. Many infections are asymptomatic, facilitating silent spread. It may lead to PID, epididymitis, and, rarely, disseminated disease. NAATs and cultures diagnose gonorrhea; treatment often involves antibiotics, though multidrug-resistant strains have emerged. Dual therapy, typically an injection plus oral medication, is common in many guidelines. Prevention relies on condoms, reduced partner numbers, and regular screening for at-risk groups.
3) Trichomoniasis
Caused by the protozoan parasite Trichomonas vaginalis, trichomoniasis is one of the most common nonviral STDs globally. Symptoms can include genital itching, discharge, and discomfort, but many people show no signs. Diagnosis uses NAATs, wet mounts, or rapid antigen tests. It is treatable with antiparasitic medications, usually metronidazole or tinidazole. Correct and consistent condom use lowers transmission risk, and partners may need treatment to prevent reinfection.
4) Syphilis
Treponema pallidum causes syphilis, which progresses through stages—primary, secondary, latent, and tertiary—each with distinct signs. Primary syphilis features a painless chancre; secondary may involve rash and mucous membrane lesions. Latent syphilis has no symptoms but can cause severe damage years later. T pallidum is diagnosed with blood tests and, if needed, darkfield microscopy or biopsy of lesions. Early syphilis is curable with antibiotics, typically penicillin, while late stages focus on preventing progression. Screening during pregnancy is critical to prevent congenital syphilis.
5) Mycoplasma genitalium
Mycoplasma genitalium is a growing public health concern due to rising detection and antibiotic resistance. It can cause urethritis, cervicitis, and PID, sometimes with few symptoms. NAATs identify M genitalium; treatment may require longer or combination antibiotic regimens guided by susceptibility testing. Because of resistance patterns, consulting a clinician familiar with local guidelines is important. Barrier methods and regular screening in at-risk populations support prevention.
6) HIV
Human immunodeficiency virus attacks the immune system and, without treatment, can lead to acquired immunodeficiency syndrome (AIDS). Modern antiretroviral therapy allows people with HIV to live long, healthy lives and achieve undetectable viral loads, which prevents sexual transmission (U=U: Undetectable = Untransmittable). Testing identifies infection early, enabling timely care and prevention of onward transmission. Pre-exposure prophylaxis (PrEP) greatly reduces acquisition risk for high-risk groups. Condom use and not sharing needles further lower risk.
7) Hepatitis B
Hepatitis B virus (HBV) infects the liver and can cause acute or chronic disease. Chronic infection raises the risk of cirrhosis and liver cancer. Vaccination is highly effective and recommended for all infants and unvaccinated adults at risk. HBV can sometimes be cleared by the immune system, but chronic cases require long-term management. Testing identifies infection and immunity; antiviral medications can suppress viral replication. Using condoms and not sharing drug-injection equipment reduce risk.
8) Herpes simplex virus
HSV types 1 and 2 cause oral and genital herpes. After infection, the virus remains in nerve cells and can reactivate, causing outbreaks of sores. Many people have mild or no symptoms but can still transmit the virus. Antiviral medications can shorten outbreaks and lower transmission risk. Condoms reduce but do not eliminate risk, because lesions can occur outside condom coverage. Suppressive therapy can decrease transmission to partners. Open communication with partners supports informed choices.
9) Human papillomavirus
HPV is extremely common and often clears on its own, but some high-risk types can cause cancers of the cervix, anus, throat, and other sites. HPV vaccination dramatically reduces the risk of vaccine-covered types. Screening with Pap tests and HPV tests detects precancerous changes early, allowing timely treatment. There is no routine treatment for the virus itself, but related diseases are manageable. Condoms lower, but do not block, transmission because HPV can infect areas not covered by condoms.
10) Other reported STDs
Depending on local surveillance, other infections such as bacterial vaginosis, pubic lice, and scabies may appear in top STD lists based on clinical encounters and reporting. Bacterial vaginosis is a change in vaginal flora rather than a classic STD, though sexual activity can influence risk. Lice and scabies are typically considered separately from STI surveillance systems in many countries. Local health departments can clarify which conditions are tracked as STDs in a specific area.
Testing and when to get tested
Many STDs are asymptomatic, so regular screening is essential for sexually active people with risk factors. Testing frequency depends on behavior, partner status, and local guidelines. Common recommendations include annual chlamydia and gonorrhea screening for sexually active women under 25 and older women with risk factors; yearly HIV testing for at least adults aged 13 to 64, with more frequent testing for higher risk; and periodic syphilis testing based on risk. Pregnant people should be screened early in pregnancy and again when indicated. If exposed, test after the appropriate window period; discuss timing with a clinician. Telehealth services and community clinics can expand access to testing.
Testing methods and timing overview
| Infection | Typical test type | Common sample | Notes on timing |
|---|---|---|---|
| Chlamydia & gonorrhea | Nucleic acid amplification test (NAAT) | Urine or swab | Can detect infection soon after exposure; annual screening recommended for many. |
| Syphilis | Blood tests (non-treponemal and treponemal) | Serum or plasma | Window varies; non-treponemal tests may be used for monitoring after treatment. |
| HIV | Combination antigen/antibtest or antibody test | Blood or oral fluid | Antigen/antib test can detect earlier; follow confirmatory testing per guidelines. |
| Trichomoniasis | NAAT, rapid antigen, wet mount | Urine or swab | NAAT is highly sensitive; consider testing if symptoms or risk factors. |
| Herpes | Viral culture, PCR, blood type | Swab of lesion or blood |
Treatment and management
Treatment depends on the pathogen and infection stage. Bacterial STDs such as chlamydia, gonorrhea, and syphilis are typically curable with antibiotics, though adherence and follow-up testing are important. Trichomoniasis is also treatable with antiparasitic drugs. Viral STDs like herpes and HIV cannot be cured but can be managed with medication that reduces symptoms, viral shedding, and transmission risk. Hepatitis B may require long-term antiviral therapy to control replication and prevent complications. Consistent follow-up, completing prescribed courses, and notifying recent partners are key components of effective management. Healthcare providers can offer guidance tailored to the specific infection and individual health needs.
Prevention and safer sex practices
Preventing STDs involves a combination of behavioral strategies, vaccination, and regular screening. Condoms, when used correctly and consistently, reduce the risk of many STDs but may not fully protect against infections spread by skin-to-skin contact, such as HPV and herpes. HPV vaccination protects against the most common cancer- and wart-causing types; catch-up vaccination is recommended through early adulthood for those who were not previously vaccinated. Mutual monogamy with an uninfected partner and regular testing reduce risk. Limiting alcohol and avoiding drug use can support safer decision-making. For people at substantial risk, PrEP and, in the case of HBV, vaccination are highly effective prevention tools. Discuss risk reduction with a healthcare provider to tailor strategies to individual circumstances.
When to seek medical care
Seek care promptly if you have symptoms such as unusual discharge, sores, rashes, painful urination, or pelvic pain, or if a partner informs you of an STD diagnosis. Many infections are asymptomatic, so routine screening is important even without symptoms. Early diagnosis and treatment lower the risk of complications and reduce the chance of passing infections to partners. If you are pregnant or planning pregnancy, inform your clinician so appropriate testing and care can be provided. Community health centers and telehealth services can provide confidential, judgment-free evaluation and treatment.
Reliable information and support
For trustworthy guidance, consult clinicians, local health departments, and reputable organizations. Resources such as national STD hotlines, Planned Parenthood, and public health agencies offer accurate information, testing locations, and, where available, low-cost or free services. Online tools can help clarify questions about symptoms, testing intervals, and prevention, but they do not replace professional medical advice. Open conversations with partners and providers support informed decisions and better sexual health outcomes over time.
Understanding the most common STDs empowers people to protect themselves and their partners. Regular screening, effective prevention, and timely treatment are the cornerstones of long-term sexual health. By combining vaccines, consistent condom use, reduced-risk behaviors, and clinician-guided care, individuals can meaningfully lower their risk and contribute to public health efforts to reduce STD burden.